ARTANN Laboratories Inc Product Pipeline Analysis, 2018 Update [Report Updated: 30052018] Prices from USD $750

17:26 EDT 1 Aug 2018 | BioPortfolio Reports

Summary


Artann Laboratories Inc Artann is a medical device company that provides ultrasound solutions. The company offers early stage development and validation of original technologies and devices. Its products include tissue elastometers and breast models. Artann's products provide processing of technologies such as mechanical imaging, breast mechanical imaging, bone ultrasonometry, colonoscopy force monitor, vaginal tactile imager, and others. The company offers shear wave elasticity imaging, temperature profile spectroscopy, droplet, prostate mechanical imaging, body hydration monitor, and time reversal acoustics. Its products are used in medical, aerospace and military applications. The company's MI devices are used for prostate, breast, vagina and muscle abnormalities imaging. It distributes its products in different parts of the US. Artann is headquartered in West Trenton, New Jersey, the US.


This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.


Scope:


The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company ARTANN Laboratories Inc

The report provides pipeline analysis on all pipeline products of the company by equipment type, by indication, by development stage, and by trial status

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indications, applications and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials wherever applicable with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.


Reasons to Buy:


Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research Development strategies

Develop marketentry and market expansion strategies

Exploit inlicensing and outlicensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next highvalue products that your competitor would add in its portfolio


Note: Some sections may be missing if data is unavailable for the company

More From BioPortfolio on "ARTANN Laboratories Inc Product Pipeline Analysis, 2018 Update [Report Updated: 30052018] Prices from USD $750"